- Home
- ANAB vs OXM Comparison
ANAB vs OXM Comparison
Compare ANAB & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANAB
- OXM
- Stock Information
- Founded
- ANAB 2005
- OXM 1942
- Country
- ANAB United States
- OXM United States
- Employees
- ANAB N/A
- OXM N/A
- Industry
- ANAB Biotechnology: Pharmaceutical Preparations
- OXM Apparel
- Sector
- ANAB Health Care
- OXM Consumer Discretionary
- Exchange
- ANAB Nasdaq
- OXM Nasdaq
- Market Cap
- ANAB 759.5M
- OXM 734.5M
- IPO Year
- ANAB 2017
- OXM N/A
- Fundamental
- Price
- ANAB $20.55
- OXM $44.80
- Analyst Decision
- ANAB Buy
- OXM Hold
- Analyst Count
- ANAB 10
- OXM 5
- Target Price
- ANAB $36.38
- OXM $62.00
- AVG Volume (30 Days)
- ANAB 1.0M
- OXM 630.0K
- Earning Date
- ANAB 05-08-2025
- OXM 06-11-2025
- Dividend Yield
- ANAB N/A
- OXM 6.14%
- EPS Growth
- ANAB N/A
- OXM 53.66
- EPS
- ANAB N/A
- OXM 5.87
- Revenue
- ANAB $91,280,000.00
- OXM $1,516,601,000.00
- Revenue This Year
- ANAB N/A
- OXM N/A
- Revenue Next Year
- ANAB $37.76
- OXM $2.59
- P/E Ratio
- ANAB N/A
- OXM $7.63
- Revenue Growth
- ANAB 432.03
- OXM N/A
- 52 Week Low
- ANAB $12.21
- OXM $44.40
- 52 Week High
- ANAB $41.31
- OXM $111.46
- Technical
- Relative Strength Index (RSI)
- ANAB 65.12
- OXM 33.62
- Support Level
- ANAB $15.40
- OXM $44.40
- Resistance Level
- ANAB $19.82
- OXM $52.00
- Average True Range (ATR)
- ANAB 1.49
- OXM 4.29
- MACD
- ANAB 0.16
- OXM -0.87
- Stochastic Oscillator
- ANAB 96.26
- OXM 14.18
About ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
About OXM Oxford Industries Inc.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates majority of its revenue from the Tommy Bahama division.